Introduced by Senator Elizabeth Warren (D-MA), Medical Innovation Act proposes to increase funding for the National Institutes of Health by creating a new statutory scheme that would impose fee on biopharmaceutical companies working on critical treatments and cures for patients. According to BIO President and CEO, Jim Greenwood, BIO supports increased funding for NIH, but has serious concerns about the impact this legislation would have on research and development.